Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | New Studies Show Effectiveness of Reflective Confocal MicroscopyThree new studies published in peer reviewed journals of dermatology have further demonstrated the effectiveness of reflective confocal microscopy (RCM) as a diagnostic tool in dermatology.
By: Lucid, Inc. “These findings are quite encouraging, especially as we continue to launch pilots throughout Europe and the United States that are expected to demonstrate the success of RCM in routine private practice use,” he added. Lucid, an innovative cellular imaging and technology company, is creator of the non-invasive VivaScope® reflective confocal microscope that provides cellular resolution images of skin and the VivaNet™, an Internet-based, DICOM-compliant application that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images. The three articles Eastman cited are: • “Diving into the blue: In vivo microscopic characterization of the dermoscopic blue hue,” in the July 2007 issue of the Journal of the American Academy of Dermatology. The article details a study that sought to identify “the in vivo confocal microscopy correlates of the blue hue for improving diagnostic accuracy for melanoma,” and determined that “confocal microscopy enabled the in vivo identification of characteristic cytological substrates correlated with the blue features in dermoscopy.” • “In vivo reflectance confocal microscopy of mycosis fungoides: A preliminary study,” in the April 2007 issue of the Journal of American Academy of Dermatology. The study objective “was to evaluate lesions suggestive of MF (mycosis fungoides) using in vivo reflectance confocal microscopy (RCM) and to correlate confocal features with histopathologic findings.” Study results found that “…features correlating well to histophathology are observed on RCM of MF lesions.” The article, by authors: AL. Agero, M. Gill, M. Ardigo, P. Myskowski, AC. Halpern, S. Gonzalez, was published online April 13, 2007 and can be accessed at: http://www.ncbi.nlm.nih.gov/ • “Preliminary evaluation of in vivo reflectance confocal microscopy features of discoid lupus erythematosus,” For more information about Lucid and their reflective confocal technologies, visit www.lucid-tech.com or call 1-585-239-9800. About Lucid Inc. Lucid Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. When coupled with its digital VivaNetTM system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit www.Lucid-tech.com. # # # Lucid Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. When coupled with its digital VivaNetTM system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. Website: www.lucid-tech.com End
| |||||||||||||||||||||||||||||||||||||||||||
